SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 8.97% to Rs. 5650.10 millions for the quarter ended June 2022 as compared to Rs. 5185.10 millions during the corresponding quarter last year.The Company to register a -47.93%  fall in the net profit for the quarter ended June 2022.Operating Profit reported a sharp decline to 611.70 millions from 1158.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 5650.10 5185.10 8.97 5650.10 5185.10 8.97 21840.20 19669.80 11.03
Other Income 51.50 57.20 -9.97 51.50 57.20 -9.97 320.40 243.00 31.85
PBIDT 611.70 1158.70 -47.21 611.70 1158.70 -47.21 2883.20 6161.40 -53.21
Interest 33.80 17.70 90.96 33.80 17.70 90.96 82.90 58.30 42.20
PBDT 577.90 1001.70 -42.31 577.90 1001.70 -42.31 2661.00 6103.10 -56.40
Depreciation 109.80 103.20 6.40 109.80 103.20 6.40 432.60 389.20 11.15
PBT 468.10 898.50 -47.90 468.10 898.50 -47.90 2228.40 5713.90 -61.00
TAX 119.20 228.50 -47.83 119.20 228.50 -47.83 571.80 1268.30 -54.92
Deferred Tax -2.40 -6.20 -61.29 -2.40 -6.20 -61.29 1.70 -187.20 -100.91
PAT 348.90 670.00 -47.93 348.90 670.00 -47.93 1656.60 4445.60 -62.74
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 10.83 22.35 -51.55 10.83 22.35 -51.55 13.20 31.32 -57.86

IOL Chem & Pharma Share Price

96.98 -0.90 (-0.92%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×